JP2011527181A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527181A5
JP2011527181A5 JP2011516935A JP2011516935A JP2011527181A5 JP 2011527181 A5 JP2011527181 A5 JP 2011527181A5 JP 2011516935 A JP2011516935 A JP 2011516935A JP 2011516935 A JP2011516935 A JP 2011516935A JP 2011527181 A5 JP2011527181 A5 JP 2011527181A5
Authority
JP
Japan
Prior art keywords
nucleic acid
rha
plant
hemagglutinin
host cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011516935A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011527181A (ja
JP5809054B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2009/000941 external-priority patent/WO2010003235A1/en
Publication of JP2011527181A publication Critical patent/JP2011527181A/ja
Publication of JP2011527181A5 publication Critical patent/JP2011527181A5/ja
Application granted granted Critical
Publication of JP5809054B2 publication Critical patent/JP5809054B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011516935A 2008-07-08 2009-07-07 可溶性組換えインフルエンザ抗原 Expired - Fee Related JP5809054B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7896308P 2008-07-08 2008-07-08
US61/078,963 2008-07-08
PCT/CA2009/000941 WO2010003235A1 (en) 2008-07-08 2009-07-07 Soluble recombinant influenza antigens

Publications (3)

Publication Number Publication Date
JP2011527181A JP2011527181A (ja) 2011-10-27
JP2011527181A5 true JP2011527181A5 (cg-RX-API-DMAC7.html) 2012-08-23
JP5809054B2 JP5809054B2 (ja) 2015-11-10

Family

ID=41506627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011516935A Expired - Fee Related JP5809054B2 (ja) 2008-07-08 2009-07-07 可溶性組換えインフルエンザ抗原

Country Status (10)

Country Link
US (1) US8771703B2 (cg-RX-API-DMAC7.html)
EP (1) EP2294202B1 (cg-RX-API-DMAC7.html)
JP (1) JP5809054B2 (cg-RX-API-DMAC7.html)
CN (2) CN102089432A (cg-RX-API-DMAC7.html)
AU (1) AU2009267769B2 (cg-RX-API-DMAC7.html)
CA (1) CA2730171C (cg-RX-API-DMAC7.html)
DK (1) DK2294202T3 (cg-RX-API-DMAC7.html)
ES (1) ES2545607T3 (cg-RX-API-DMAC7.html)
PT (1) PT2294202E (cg-RX-API-DMAC7.html)
WO (1) WO2010003235A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009076778A1 (en) 2007-11-27 2009-06-25 Medicago Inc. Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
CA2787099A1 (en) 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
BRPI1015053A2 (pt) 2009-06-24 2019-07-09 Medicago Inc partículas similares a vírus da influenza quiméricas compreendendo hemaglutinina
SI3354657T1 (sl) 2009-09-22 2022-05-31 Medicago Inc. Postopek za pripravo iz rastlin izpeljanih beljakovin
US9701723B2 (en) 2010-02-18 2017-07-11 Icahn School Of Medicine At Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
WO2011123495A1 (en) 2010-03-30 2011-10-06 Mount Sinai School Of Medicine Influenza virus vaccines and uses thereof
CA2805741C (en) * 2010-07-23 2019-08-13 Karin Bengtsson Loevgren Composition including an iscom matrix and ectodomains
US20130259928A1 (en) * 2010-09-30 2013-10-03 Franvax S.R.L. Generation of virosome particles
TWI526539B (zh) 2010-12-22 2016-03-21 苜蓿股份有限公司 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
EP2681232A1 (en) * 2011-03-02 2014-01-08 Intervet International B.V. Infectious bronchitis virus (ibv) spike protein as subunit vaccine
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
EP2758075B1 (en) * 2011-09-20 2023-05-03 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
RU2682752C2 (ru) 2011-09-30 2019-03-21 Медикаго Инк. Повышение выхода вирусоподобных частиц в растениях
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
EP2934581B1 (en) 2012-12-18 2022-09-14 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
KR102199018B1 (ko) 2013-03-28 2021-01-07 메디카고 인코포레이티드 식물에서 인플루엔자 바이러스-유사 입자 생산
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
JP2018504412A (ja) 2015-01-23 2018-02-15 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルスワクチン接種レジメン
TW201731865A (zh) * 2016-03-15 2017-09-16 國立清華大學 重組h7血凝素及其應用
EP3471767A4 (en) 2016-06-15 2020-01-15 Icahn School of Medicine at Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
US11696948B2 (en) 2018-06-12 2023-07-11 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11690907B2 (en) 2018-06-12 2023-07-04 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
SG11202012366WA (en) * 2018-06-12 2021-01-28 Kentucky Bioprocessing Inc Virus and antigen purification and conjugation
US11529413B2 (en) 2018-06-12 2022-12-20 Kbio Holdings Limited Virus and antigen purification and conjugation
WO2019246363A1 (en) 2018-06-21 2019-12-26 Icahn School Of Medicine At Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
JP2021528970A (ja) 2018-06-27 2021-10-28 メディカゴ インコーポレイテッド インフルエンザウイルスヘマグルチニン変異体
WO2020219719A1 (en) 2019-04-24 2020-10-29 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
CN115003328A (zh) 2019-10-22 2022-09-02 西奈山伊坎医学院 重组神经氨酸酶及其用途
CN115867662A (zh) * 2020-04-22 2023-03-28 浦项工科大学校产学协力团 形成三聚体的新型冠状病毒肺炎(covid-19)重组刺突蛋白、在植物中大量产生重组刺突蛋白的方法和基于其制备疫苗组合物的方法
WO2021249013A1 (en) * 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Vaccine compositions, methods, and uses thereof
CN111662390A (zh) * 2020-06-17 2020-09-15 天康生物(上海)有限公司 禽流感HA-Fd融合蛋白及其制备方法和疫苗
CN114773487B (zh) * 2022-05-31 2024-07-02 湖南大学 一种流感病毒和新型冠状病毒融合重组蛋白疫苗免疫原及其制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003224A1 (en) 1984-11-29 1986-06-05 Scripps Clinic And Research Foundation Polypeptides and antibodies related to deglycosylated viral glycoproteins
US5232833A (en) 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
DE69213804T2 (de) 1991-03-28 1997-03-27 Rooperol Na Nv Zusammensetzungen von Phytosterolen mit Phytosterolinen als Immunmodulatoren
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
GB9409768D0 (en) 1994-05-16 1994-07-06 Medical Res Council Trimerising polypeptides
AU736707B2 (en) 1997-06-11 2001-08-02 Anaphore, Inc. Trimerising module
US20010006950A1 (en) 1998-02-11 2001-07-05 Juha Punnonen Genetic vaccine vector engineering
US6489537B1 (en) 1998-08-07 2002-12-03 The Trustees Of The University Of Pennsylvania Phytochelatin synthases and uses therefor
NZ510358A (en) 1998-08-11 2002-09-27 Large Scale Biology Corp Method for recovering proteins from the interstitial fluid of plant tissues
US6392121B1 (en) 1998-10-07 2002-05-21 Boyce Thompson Institute For Plant Research Gemini virus vectors for gene expression in plants
FR2791358B1 (fr) 1999-03-22 2003-05-16 Meristem Therapeutics Promoteurs chimeriques d'expression, cassettes d'expression, plasmides, vecteurs, plantes et semences transgeniques les contenant et leurs methodes d'obtention
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
US7449188B2 (en) 2001-01-18 2008-11-11 Vlaams Interuniversitair Instituut Voor Biotechnologie Recombinant oligometric protein complexes with enhanced immunogenic potential
EP3009507B1 (en) 2002-02-13 2020-06-24 Wisconsin Alumini Research Foundation Signal for packaging of influenza virus vectors
WO2003068804A2 (en) 2002-02-14 2003-08-21 Novavax, Inc. Novel insect cell line
CA2478294C (en) 2002-03-19 2013-09-03 Plant Research International B.V. Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants
ES2224792B1 (es) * 2002-06-28 2007-02-16 Era Plantech, S.L. Produccion de peptidos y proteinas por acumulacion de cuerpos proteicos derivados de reticulos endoplasmico en plantas.
KR20060035596A (ko) 2003-05-05 2006-04-26 보이스 톰슨 인스터튜트 포 플랜트 리서치 외래유전자도입 식물로부터 유래된 면역보호성 조성물을제조하기 위한 벡터와 세포
KR20060029214A (ko) 2003-05-05 2006-04-05 다우 아그로사이언시즈 엘엘씨 이식 유전자 식물 세포들로부터 유래된 안정한 면역예방적및 치료적 조성물들 및 생산방법
EP1633312A4 (en) 2003-06-16 2012-09-26 Medimmune Llc INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
CN101166827B (zh) 2005-04-29 2013-09-04 开普敦大学 在植物中表达蛋白质
JP2009502789A (ja) 2005-07-19 2009-01-29 ダウ グローバル テクノロジーズ インコーポレイティド 組み換えインフルエンザワクチン
US20070042002A1 (en) * 2005-08-16 2007-02-22 Hawaii Biotech, Inc. Influenza recombinant subunit vaccine
PT1937301E (pt) 2005-10-18 2015-09-14 Novavax Inc Partículas idênticas a vírus (vlps) da gripe funcionais
US8124103B2 (en) 2006-02-13 2012-02-28 Fraunhofer Usa, Inc Influenza antigens, vaccine compositions, and related methods
JP2009535306A (ja) 2006-04-21 2009-10-01 ダウ・アグロサイエンス・エル・エル・シー 鳥インフルエンザに対するワクチンおよび使用方法
WO2007130327A2 (en) 2006-05-01 2007-11-15 Technovax, Inc. Influenza virus-like particle (vlp) compositions
EP2023952B1 (en) 2006-05-18 2015-07-15 Epimmune Inc. Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
US20070286873A1 (en) 2006-05-23 2007-12-13 Williams John V Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
PL2155880T3 (pl) 2007-06-15 2017-06-30 Medicago Inc. Modyfikacja wytwarzania glikoproteiny w roślinach
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
WO2009076778A1 (en) 2007-11-27 2009-06-25 Medicago Inc. Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
CA2696764A1 (en) * 2007-08-20 2009-02-26 Fraunhofer Usa, Inc. Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
GB0800272D0 (en) 2008-01-08 2008-02-13 Plant Bioscience Ltd Protein expression systems
EA034733B1 (ru) 2008-01-21 2020-03-13 Медикаго Инк. Нуклеиновая кислота для увеличенной экспрессии гемагглютинина вируса гриппа в растении и ее применение
DE102008009491B4 (de) 2008-02-15 2010-02-04 Rainer Brenner Vorrichtung zur Sicherung von Waren
DK2318530T3 (en) 2008-07-18 2016-10-03 Medicago Inc Ny epitope to immunization against influenza
WO2010025285A1 (en) 2008-08-27 2010-03-04 Arizona Board Of Regents For And On Behalf Of Arizona State University A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
WO2010077712A1 (en) 2008-12-09 2010-07-08 Novavax, Inc. Bovine respiratory syncytial virus virus-like particle (vlps)
BRPI1015053A2 (pt) 2009-06-24 2019-07-09 Medicago Inc partículas similares a vírus da influenza quiméricas compreendendo hemaglutinina

Similar Documents

Publication Publication Date Title
JP5809054B2 (ja) 可溶性組換えインフルエンザ抗原
WO2011098999A3 (en) Chemical preparation of ubiquitin thioesters and modifications thereof
CN110709518B (zh) 携带纤维素结合域的重组载体和用该载体分离并纯化蛋白质的方法
JP2012531208A5 (cg-RX-API-DMAC7.html)
JP2012095652A5 (cg-RX-API-DMAC7.html)
CN103214563B (zh) 一种性能改进的重组金黄色葡萄球菌蛋白a亲和配基及其构建方法
CN110177811A (zh) 用于蛋白质连接的方法及其用途
ATE527345T1 (de) Chimäres fusionsprotein mit überlegenen chaperon- und faltungsaktivitäten
JP2023539356A5 (cg-RX-API-DMAC7.html)
CN107267537B (zh) 一种杂合抗菌肽mlh的制备方法
WO2010104357A4 (ko) 환자맞춤형 줄기세포치료를 위한 세포투과성 역분화 전사인자를 이용한 유도만능줄기세포 확립
NZ590011A (en) Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
KR20250154428A (ko) 펩티드의 제조 및 정제를 위한 방법 및 조성물
JP2010183921A5 (cg-RX-API-DMAC7.html)
RU2016132865A (ru) Энхансерные элементы cpmv
GB0608368D0 (en) Process for making Oligopeptides
CN103255151B (zh) 表达量高和活性强的cvn突变体的编码序列及其应用
EP3215608A1 (en) Modified heterocyclase
CN117264075A (zh) 一种猪流行性腹泻病毒多表位融合蛋白及其制备方法和应用
CN103965341B (zh) 一种细菌结合蛋白、其编码基因、以此基因为目的基因生产的融合蛋白及其应用
EP4265636A1 (en) Preparation of target peptides and proteins
Greenshields et al. Strategies for recombinant expression of small, highly disulphide-bonded, cationic antimicrobial peptides
CN108034670A (zh) 一种食源性大豆生物活性肽Lunasin的无柱式、低成本制备方法
Liang et al. Crystal optimization and preliminary diffraction data analysis of the SCAN domain of Zfp206
WO2009031852A3 (en) Preparation method of recombinant protein by use of a fusion expression partner